In obese individuals, the level of indole is reduced, leading to the disruption of its role in enhancing the intestinal barrier and improving metabolic homeostasis after binding with AhR, while the accumulation of kynurenine promotes inflammation, energy imbalance, and fat deposition, ultimately resulting in obesity [27,28]. The gene discussed is AHR; the disease is obesity disorder.